CompletedNCT05035316
Low-dose aspirin study for people with bipolarity
About this title
Read the official source — NCT05035316Medication studyAges 18–65Denmark
Understand this study
Who was this study for?
This study was for people with bipolarity. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.
- Listed locations
- CopenhagenSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateStarted: January 20, 2022
- Recruitment status
- Completed
- Enrollment listed in the registry
- 250
- Sponsor
- Lars Vedel Kessing
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- Denmark
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT05035316
- Official title
Show the full official title
Effects of Low Dose Aspirin in Bipolar Disorder (The A-Bipolar RCT)
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Copenhagen
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Lars Vedel Kessing.
Did this study involve medication?
Yes. The study involved medication, including acetylsalicylic acid and Calcium.
Who was this study for?
This study was for people with bipolarity. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.
